BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22831649)

  • 1. Elevation of tau protein levels in the cerebrospinal fluid of children with West syndrome.
    Inoue H; Matsushige T; Hasegawa S; Abe A; Iida Y; Inoue T; Ichiyama T
    Epilepsy Res; 2012 Nov; 102(1-2):8-12. PubMed ID: 22831649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau protein concentrations in the cerebrospinal fluid of children with acute disseminated encephalomyelitis.
    Oka M; Hasegawa S; Matsushige T; Inoue H; Kajimoto M; Ishikawa N; Isumi H; Ichiyama T
    Brain Dev; 2014 Jan; 36(1):16-20. PubMed ID: 23291220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACTH therapy for Taiwanese children with West syndrome -- efficacy and impact on long-term prognosis.
    Lin HC; Young C; Wang PJ; Lee WT; Shen YZ
    Brain Dev; 2006 Apr; 28(3):196-201. PubMed ID: 16466880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study of conventional dose and low dose adrenocorticotrophic hormone therapy for West syndrome].
    Shu XM; Li J; Zhang GP; Mao Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):445-8. PubMed ID: 19558807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome.
    Yamanaka G; Kawashima H; Oana S; Ishida Y; Miyajima T; Kashiwagi Y; Hoshika A
    J Neurol Sci; 2010 Nov; 298(1-2):106-9. PubMed ID: 20807663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF ACTH and beta-endorphin in infants with West syndrome and ACTH therapy.
    Heiskala H
    Brain Dev; 1997 Jul; 19(5):339-42. PubMed ID: 9253486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. West syndrome: cerebrospinal fluid nerve growth factor and effect of ACTH.
    Riikonen RS; Söderström S; Vanhala R; Ebendal T; Lindholm DB
    Pediatr Neurol; 1997 Oct; 17(3):224-9. PubMed ID: 9390698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The axonal damage marker tau protein in the cerebrospinal fluid is increased in patients with acute encephalopathy with biphasic seizures and late reduced diffusion.
    Tanuma N; Miyata R; Kumada S; Kubota M; Takanashi J; Okumura A; Hamano S; Hayashi M
    Brain Dev; 2010 Jun; 32(6):435-9. PubMed ID: 19679415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial seizures during ACTH therapy in a cryptogenic West syndrome patient.
    Fukui M; Shimakawa S; Tanabe T; Nomura S; Kashiwagi M; Azumakawa K; Tamai H
    Brain Dev; 2014 Jan; 36(1):80-3. PubMed ID: 23352589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-duration ACTH therapy for cryptogenic West syndrome with better outcome.
    Hattori A; Ando N; Hamaguchi K; Hussein MH; Fujimoto S; Ishikawa T; Togari H
    Pediatr Neurol; 2006 Dec; 35(6):415-8. PubMed ID: 17138011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated cerebrospinal fluid tau protein levels in Wernicke's encephalopathy.
    Matsushita S; Miyakawa T; Maesato H; Matsui T; Yokoyama A; Arai H; Higuchi S; Kashima H
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1091-5. PubMed ID: 18445112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin as a first-line drug in West syndrome: clinical and electroencephalographic outcome.
    Wohlrab G; Boltshauser E; Schmitt B
    Neuropediatrics; 1998 Jun; 29(3):133-6. PubMed ID: 9706623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis.
    Terzi M; Birinci A; Cetinkaya E; Onar MK
    Acta Neurol Scand; 2007 May; 115(5):325-30. PubMed ID: 17489943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level of tau protein in children treated for acute lymphoblastic leukemia.
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
    Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF tau protein: a new prognostic marker for Guillain-Barré syndrome.
    Jin K; Takeda A; Shiga Y; Sato S; Ohnuma A; Nomura H; Arai H; Kusunoki S; Ikeda M; Itoyama Y
    Neurology; 2006 Oct; 67(8):1470-2. PubMed ID: 17060576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ACTH and prednisolone in infantile spasms: experience from a developing country.
    Azam M; Bhatti N; Krishin J
    Seizure; 2005 Dec; 14(8):552-6. PubMed ID: 16183305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term weekly ACTH therapy for relapsed West syndrome.
    Okanishi T; Sugiura C; Saito Y; Maegaki Y; Ohno K; Togari H
    Pediatr Neurol; 2008 Jun; 38(6):445-9. PubMed ID: 18486831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients.
    de Bont JM; Vanderstichele H; Reddingius RE; Pieters R; van Gool SW
    Eur J Paediatr Neurol; 2008 Jul; 12(4):334-41. PubMed ID: 17951083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocarnosine levels in cerebrospinal fluid of patients with infantile spasms under ACTH therapy.
    Ohtsuka C; Sato Y; Takahashi H
    Brain Dev; 1983; 5(5):464-8. PubMed ID: 6318586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.